INTC Research Update — August 28, 2026 (Updated)
Updated Thesis
Intel is a semiconductor designer and manufacturer operating through CCG, DCAI, and Intel Foundry segments, facing intense competition from AMD and NVIDIA. The company's most recent quarter showed revenue growth of 25.4% year-over-year, but earnings declined 278.1%, reflecting significant profitability challenges. TTM net margin is -19.8%, and the stock trades at a very expensive valuation regime with a P/S of 8.47 and EV/EBITDA of 141.85.
The investment grade as of this refresh is D — solid business quality. Low-tier business, very expensive valuation with 32.5% downside to $64.65 fair value.
Key Metrics at a Glance
- Revenue growth: +25.4% year over year
- Net margin: -19.8%
- Fair value upside: -32.5% to our estimate of $65
Current price: $95.80
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Intel Corp. remains in our covered universe with a solid-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full INTC research →](/stocks/INTC)